Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1
Dengqiu Xu, Lei Zhao, Jingwei Jiang, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 5, pp. 1306-1320
Open Access | Times Cited: 25

Showing 25 citing articles:

Duchenne muscular dystrophy: pathogenesis and promising therapies
Mengyuan Chang, Yong Cai, Zihui Gao, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 3733-3749
Closed Access | Times Cited: 26
Proteome Analysis Reveals Paraspinal Muscle Fiber Type Changes in Patients with Degenerative Lumbar Scoliosis
Abdukahar Kiram, Jie Li, Wei Liu, et al.
The Spine Journal (2025)
Closed Access
TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseases
Kun Huang, Qí Zhāng, Hao Wan, et al.
FEBS Journal (2025)
Closed Access
Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy
Xiaofei Huang, Sijia Li, Huna Wang, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy
Anirban Roy, Ashok Kumar
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
Nicolas Dubuisson, Romain Versele, Chloé Planchon, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16080-16080
Open Access | Times Cited: 16
TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy
Dengqiu Xu, Sijia Li, Lu Wang, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 12, Iss. 1, pp. 192-208
Open Access | Times Cited: 21
Comprehensive analysis of 2097 patients with dystrophinopathy based on a database from 2011 to 2021
Lei Zhao, Yiyun Shi, Chaoping Hu, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy
Marine Théret, Marcela Low, Lucas Rempel, et al.
Life Sciences (2021) Vol. 279, pp. 119482-119482
Open Access | Times Cited: 14
MCT2 overexpression promotes recovery of cognitive function by increasing mitochondrial biogenesis in a rat model of stroke
Xiaorong Yu, Rui Zhang, Cunsheng Wei, et al.
Animal Cells and Systems (2021) Vol. 25, Iss. 2, pp. 93-101
Open Access | Times Cited: 13
Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway
Dengqiu Xu, Lei Zhao, Sijia Li, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 7, pp. 1080-1089
Open Access | Times Cited: 13
CXCL10 impairs synaptic plasticity was modulated by cGAS-STING pathway after stroke in mice
Yi Wang, Juan Du, Youfang Hu, et al.
Journal of Neurophysiology (2024) Vol. 132, Iss. 3, pp. 722-732
Closed Access | Times Cited: 1
A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation
Zeren Sun, Dengqiu Xu, Lei Zhao, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1237-1250
Open Access | Times Cited: 9
Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice
Yosuke Matsubara, Yuko Miyama, Ryota Imai, et al.
Bioscience Biotechnology and Biochemistry (2022)
Open Access | Times Cited: 5
Emerging role of TAK1 in the regulation of skeletal muscle mass
Anirban Roy, Vihang A. Narkar, Ashok Kumar
BioEssays (2023) Vol. 45, Iss. 4
Closed Access | Times Cited: 2
Skeletal muscle HSF1 prevents insulin resistance by improving glucose utilization
Yun Li, Shibo Lin, Xu Xu, et al.
The FASEB Journal (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 4
Apolipoprotein E knockout, but not cholesteryl ester transfer protein (CETP)-associated high-density lipoprotein cholesterol (HDL-C) lowering, exacerbates muscle wasting in dysferlin-null mice
Zeren Sun, Zoe White, Marine Théret, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Targeting fibrosis in the Duchenne Muscular Dystrophy mice model: an uphill battle
Marine Théret, Marcela Low, Lucas Rempel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020
Nicholas P. Whitehead, M.J. Kim, K. Bible, et al.
Journal of Neuromuscular Diseases (2021) Vol. 8, Iss. 5, pp. 865-866
Open Access | Times Cited: 2
Application of Reverse Docking in the Research of Small Molecule Drugs and Traditional Chinese Medicine
Hongxv Wang, Huiqin He, Tingting Zhang, et al.
Biological and Pharmaceutical Bulletin (2021) Vol. 45, Iss. 1, pp. 19-26
Open Access | Times Cited: 2
Potential Ameliorative Effects of Kampo Medicines Ninjin’yoeito and Kamikihito on Frailty-Like Behavior in Naturally Aged C57BL/6J Mice
Masashi Tabuchi, Yosuke Matsubara, Shinji Miyazaki, et al.
BPB Reports (2022) Vol. 5, Iss. 3, pp. 59-65
Open Access | Times Cited: 1
p-TAK1 acts as a switch between myoblast proliferation phase and differentiation phase in mdx mice via regulating HO-1 expression
Shusheng Fan, Xiaofei Huang, Haowei Tong, et al.
European Journal of Pharmacology (2022) Vol. 933, pp. 175277-175277
Closed Access | Times Cited: 1
A joint method for the screening of pharmacological chaperones for phenylalanine hydroxylase
Zhilei Zhang, Dingyuan Ma, Xin Wang, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 26, pp. 5827-5835
Closed Access | Times Cited: 1
Author’s Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020
Annemieke Aartsma‐Rus, Ingrid E.C. Verhaart, Dominic J. Wells
Journal of Neuromuscular Diseases (2021) Vol. 8, Iss. 5, pp. 867-868
Open Access | Times Cited: 1
Page 1

Scroll to top